A molecular screen finds compounds that directly activate RIG-I
A peer-reviewed laboratory study has identified small molecules that directly activate RIG-I, a sensor involved in innate immunity. Researchers monitored the protein’s movement and screened 14,800 compounds before testing refined candidates in cultured human cells. The work provides a chemical starting point and a screening method; it has yet to establish therapeutic benefit in animals or patients.
Science··Night
Protein movement becomes a screening signal
A peer-reviewed laboratory study found small molecules acting directly on the innate immune system’s RNA sensor, RIG-I. In its resting state, the protein holds its signalling regions against its own structure. Researchers attached a light-emitting marker and a light-quenching marker to different positions on the same protein. When the signalling regions moved apart, quenching fell. The resulting fluorescence measurement followed an early activation step instead of relying only on the cell’s eventual immune response.[1]
A compound library yields direct-binding candidates
The screen covered 14,800 compounds. Researchers removed molecules whose own fluorescence could create misleading signals, then chemically refined initial hits. Separate binding measurements tested interactions between compounds and RIG-I. A selected compound increased interferon responses and related gene activity in cultured human cells. Experiments removing RIG-I or components of its signalling pathway reduced those responses, while remaining activity indicated that specificity was not absolute.[1]
Cellular activity needs further refinement
Cell experiments required concentrations exceeding the purified-protein test levels by hundreds of times. Poor solubility and entry into cells are possible explanations that require further investigation. The work provides a screening assay and a chemical starting scaffold for refinement. Therapeutic testing in animals and clinical testing in people remain outside this work. Interferon responses in cell cultures have yet to establish a safe or effective treatment.[1]
